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2006; 
 
20:
 
 403–410.
The INMA (INfancia y Medio Ambiente [Environment and Childhood]) is a popula-
tion-based cohort study in different Spanish cities, that focuses on prenatal environ-
mental exposures and growth, development and health from early fetal life until
childhood. The study focuses on ﬁve primary areas of research: (1) growth and phys-
ical development; (2) behavioural and cognitive development; (3) asthma and aller-
gies; (4) sexual and reproductive development; and (5) environmental exposure
pathways. The general aims of the project are: (1) to describe the degree of individ-
ual prenatal exposure to environmental pollutants, and the internal dose of chemi-
cals during pregnancy, at birth and during childhood in Spain; (2) to evaluate the
impact of the exposure to different contaminants on fetal and infant growth, health
and development; (3) to evaluate the role of diet on fetal and infant growth, health
and development; and (4) to evaluate the interaction between persistent pollutants,
nutrients and genetic determinants on fetal and infant growth, health and
development.
Extensive assessments will be carried out on 3100 pregnant women and children.
Data will be collected by physical examinations, questionnaires, interviews, ultra-
sound and biological samples. Pregnant women are being assessed at 12, 20 and
32 weeks of gestation to collect information about environmental exposures and fetal
growth. The children will be followed until the age of 4 years.
 
Keywords: 
 
longitudinal cohort study, prenatal exposures, pollution, diet, genetics, study
design, biological samples, childhood growth, child development, endocrine disruptors.
 
General description
 
The INMA – INfancia y Medio Ambiente (Environ-
ment and Childhood) is a network of research groups
in Spain that built up a project aiming to study the role
of the most important environmental pollutants in air,
water and diet during pregnancy and early in life and
their effects on child growth and development.
 
Scope of research
 
The INMA project will follow up a population sample
of around 3100 pregnant mothers and newborns. New
and existing cohorts of pregnant women will be incor-
porated from eight different Spanish regions (Table 1).
The follow-up will continue until at least 2010, and, if
resources are available, until 2020.
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Genetic factors and nutritional, environmental and
psychosocial exposures in the prenatal and postnatal
periods will be evaluated. Outcomes will include
prenatal and birth health events, growth, neurodev-
elopment, behavioural functioning, immunity and
endocrine disruption. The results of these studies will
become available within the next few years, and will
help to assess pregnant women and childhood expo-
sure as well as other health determinants in several
areas of Spain and its immediate and later impacts on
human health.
 
Rationale
 
The physical, social and intellectual development of
children from conception to the end of adolescence
requires an environment that is both protected and
protective of their health. A growing number of dis-
eases in children are linked to unsafe environments.
Prenatal and early life exposures, including diet, are
associated with child health and human development
and predispose to late adult effects. Thus, the INMA
project is based on three main rationales.
First, exposure to environmental pollutants through
air, water and food is worldwide. Children are espe-
cially vulnerable to its effects as they are not just little
adults, they are still growing, and their immune sys-
tem and detoxiﬁcation mechanisms are not fully devel-
oped. Children are then more vulnerable than adults
to environmental exposures. Persistent pollutants like
organochlorine compounds (OC) and some metals
have been related to impaired intrauterine growth,
prematurity, postnatal growth and neurodevelopment
and minor behavioural disorders.
 
1–5
 
 Air pollutants e.g.
particulates have been associated with infant mortality
and with child health problems such as asthma and
allergies.
 
6,7
 
Less epidemiological evidence exists about fetal
damage, especially fetal growth, and there is a need
for further evidence.
 
8
 
 Also, chemical products in the
water, namely disinfection by-products, have been
associated with reproductive and child health out-
comes;
 
9,10
 
 this warrants further research to establish the
validity of the fundings and, if so, develop effective
preventive strategies. Little is known about the indi-
vidual susceptibility to certain chemicals, and further
studies integrating gene–environment interactions are
needed.
Second, there is growing evidence of the importance
of nutrition during pregnancy and the ﬁrst months of
life on fetal and infant growth and development, as
well as on lifelong health and well-being. Speciﬁcally,
intake of essential fatty acids (omega 3, omega 6) dur-
ing pregnancy and early postnatal life is involved in
fetal and infant growth, neurodevelopment and visual
function.
 
11,12
 
 Fish intake and supplementation with ﬁsh
oil during pregnancy has also been associated with
better postnatal neurodevelopment.
 
13–15
 
 Moreover, low
plasma levels of antioxidants and oxidative stress have
been involved in pre-eclampsia and intrauterine
growth retardation,
 
16–18
 
 and it has been suggested that
antioxidants in children have a protective inﬂuence on
the risk of asthma.
 
19,20
 
Third, some pollutants and nutrients have the same
ingestion route. Fish, the principal source of omega 3,
is also carrier of OCs and methyl-mercury. Breast
feeding, the sole form of nutrition during the ﬁrst
month of life among breast feeders, carries both
nutrients and pollutants. Although the mechanisms
of toxicity for OCs are not well understood, the sug-
gested underlying metabolic and hormonal mecha-
nisms in neurotoxicity are also in the pathway of
clinical effects due to deﬁciency of some essential
fatty acids.
 
21,22
 
 It remains to be elucidated whether
nutrients can counteract the pollutants’ negative
effects on health.
To characterise individual exposure levels during
pregnancy and childhood, to identify the role of diet
and other associated risk factors on reproductive out-
comes and child health, and to understand the inter-
actions between multiple factors and susceptibility
will contribute to early identiﬁcation of environmental
risks and to the development of protective and preven-
tive strategies.
 
Aims
 
The general aims of the project are:
 
1
 
To describe the degree of individual prenatal expo-
sure to environmental pollutants, and the internal
dose of chemicals during pregnancy, at birth and
during childhood in Spain;
 
2
 
To evaluate the impact of the exposures to different
contaminants on fetal and infant growth, health and
development; and
 
3
 
To evaluate the role of diet on fetal and infant
growth, health and development; and
 
4
 
To evaluate the interaction between persistent pol-
lutants, nutrients and genetic variants on fetal and
infant growth, health and development.
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Design
 
Overview
 
The INMA Study is a prospective population-based
cohort study concerned with the effects of pre- and
postnatal environmental exposures on growth, devel-
opment and health from early fetal life until young
adulthood.
Investigations are carried out in pregnant women
and children. Pregnant women are assessed at 12, 20
and 32 weeks of gestation to collect information about
environmental exposures and fetal growth. Children
will be assessed at birth, at the age of 1 year and at the
age of 4 years.
 
Study cohorts (Table 1)
 
The INMA is based on experience acquired by
groups studying the cohorts of Ribera d’Ebre
(
 
n
 
 = 102), which evaluated the relation between orga-
nochlorines and methyl-mercury exposure and neu-
rological development, Menorca (
 
n
 
 = 482), which
studied the relation between allergy, development
and asthma with air pollution, and Granada
(
 
n
 
 = 668), which studied the incidence of infant
reproductive health disorders in relation to potential
environmental exposures.
Based on experience from these previous studies, a
new research protocol was developed based on the
work of different working groups: exposures, effects
and design. The new cohorts have been designed to
evaluate the impact of environmental exposures and
diet on children’s health: Valencia (
 
n
 
 = 1000), Sabadell
(
 
n
 
 = 800), Asturias (
 
n
 
 = 500), Madrid (
 
n
 
 = 50) and the
Basque Country (
 
n
 
 = 800).
 
Enrolment
 
Midwives and obstetricians give eligible participants
oral information about the study and hand out an
information package to the pregnant women in the
12th week. After the visit, all eligible pregnant women
who visit the public health centre of each area have an
interview with INMA staff to obtain additional infor-
mation; they are then enrolled in the study. The inclu-
sion criteria of the mothers are: (a) to belong to the
study area (speciﬁc in each cohort), (b) to be at least
16 years old, (c) to have a singleton pregnancy, (d) to
have their ﬁrst prenatal visit (10–13 weeks of gesta-
tion) in the main public hospital or health centre of
the area, (e) to not have followed any programme of
assisted reproduction, (f) to wish to deliver in the ref-
erence hospital, and (g) to have no communication
problems. A characteristic of these areas is that a vast
majority of the population attend the public health
sector.
 
Informed consent
 
The study has been approved by the Ethical Commit-
tee of the Institut Municipal d’Investigacio Medica
and by the Ethical Committees of the hospitals
involved in the study. Pregnant women receive writ-
ten and oral information about the study. Participants
are asked for their written informed consent twice:
once for their participation in the prenatal visits and
the other time for the inclusion of their child into the
follow-up study.
 
Data collection
 
A list of all assessments planned until the age of
4 years is shown in Tables 2 and 3. More detailed infor-
mation on the INMA protocols is available upon
request.
Information is collected using a variety of sources.
Some general considerations about measurement tools
are: questionnaires are administered in an interview
format by trained interviewers; for biological samples,
total blood, plasma and serum samples are divided in
small aliquots and stored at 
 
−
 
80
 
°
 
C, urine and placentas
are stored at 
 
−
 
20
 
°
 
C until delivery to the specialised
laboratories.
 
Table 1.
 
INMA cohorts
Population
Inclusion
year
Target number
of infants 4 years
Old cohorts
Ribera de l’Ebre 1997/99 102 2001/03
Menorca 1997/98 482 2002
Granada 2001/02 668 2005/06
New cohorts
Valencia 2003/04 1000 2007
Asturias 2004/06 500 2008
Sabadell 2004/06 800 2008
Madrid 2005 50 2009
Basque Country 2005/06 800 2009
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The amount of venous maternal blood to be taken is
20 mL at 12 weeks of gestation, 15 mL from the new-
born (cord blood) and 10 mL at the age of 4 years. DNA
will be extracted from blood with ethylenediamine tet-
raacetic acid (EDTA). A 100 mL urine sample is col-
lected from the mother at 12 weeks’ gestation and the
child at the age of 4 years. A nail sample is collected
from mothers at 12 weeks’ gestation and from children
at the age of 4 years. Hair samples will be obtained at
birth and at the age of 4 years. Placentas will be col-
lected from one out of ﬁve women. Breast milk (20 mL)
will be taken at the end of the ﬁrst feeding on the third
day after delivery and will be stored at 
 
−
 
80
 
°
 
C.
 
Assessment of determinants (Table 2)
 
Air pollution:
 
•
 
Questionnaire: assessment of the exposures to traf-
ﬁc and environmental tobacco smoke during preg-
nancy (28–32 weeks) and at the ages of 1 and
4 years through a questionnaire.
 
•
 
Biological samples: measurement of hidroxypyrene
in urine in a subsample of pregnant women (at 10–
12 weeks of gestation), and children at the age of
4 years.
 
•
 
Measurement of the environment: measurement of
volatile organic compounds (VOCs), and NO
 
2
 
 in
 
Table 2.
 
Main exposures and determinants assessed in the new INMA (
 
n
 
 = 3300)
Prenatal period Postnatal period 
12 weeks 20 weeks 32 weeks Birth 1 year 4 years
 
Exposures
 
PAHs, ozone, VOCs
and NO
 
2
 
Outdoor Outdoor
Indoor (VOCs,
NO
 
2
 
)
 
a
 
Questionnaire
Questionnaire
GIS
Questionnaire
GIS
Particulates Personal
Hydroxypyrene Maternal urine Child urine
Trihalomethanes Outdoor Indoor
 
a
 
Questionnaire
Questionnaire Questionnaire
Organochlorines,
polybrominated
diphenyl ethers,
phthalates, phenols
Maternal serum Questionnaire Cord serum
Mecomium
 
b
 
Child serum
Other endocrine
disrupters
Questionnaire Placenta
Lead Cord blood Child blood
Arsenic Maternal nail Child nail
Mercury Newborn hair Child hair
Maternal occupation Questionnaire
 
Other determinants
 
Diet Questionnaire Questionnaire Questionnaire Questionnaire
Antioxidants Maternal serum Maternal milk
 
c
 
Child serum
Folate Maternal serum
Oxidative stress 
markers
Maternal serum
Maternal urine
Matenal urine Child urine
Fatty acids Maternal plasma Maternal milk
 
c
 
Cord blood
Child plasma
Genetic study Maternal blood Cord blood
Parental 
psychopathology
Questionnaire
 
a
 
In subsamples.
 
b
 
Only in the Valencia cohort.
 
c
 
Only in the Sabadell cohort.
GIS, Geographic Information System; PAH, polycyclic aromatic hydrocarbon; VOC, volatile organic compound.
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outdoor and indoor samples. Measurement of par-
ticulates, polycyclic aromatic hydrocarbons, ozone
and other pollutants in outdoor samples. Measure-
ment of particulates, VOCs, NO
 
2
 
 and ozone in air
quality registries. Measurement of personal expo-
sure to particulates in children aged 1 year. Pre-
diction of individual exposures through the
Geographic Information System.
Water pollution:
 
•
 
Questionnaires: water consumption during preg-
nancy and childhood using a questionnaire at 28–
32 weeks of gestation and at the ages of 1 and
4 years. Measurement of the environment: thriha-
lomethanes and other disinfection by-products in
water of a subsample of residences.
Persistent and semi-persistent pollutants:
 
•
 
Questionnaires: exposure during pregnancy and
childhood using a questionnaire at 28–32 weeks of
gestation and at the ages of 1 and 4 years.
 
•
 
Biological samples: measurement of OCs, polybro-
minated diphenyl ethers, phthalates and phenols
in maternal serum at 12 weeks of gestation, cord
serum and child serum at the age of 4 years.
Arsenic in maternal and child nails at the age of
4 years. Lead (in child serum) and methyl-mercury
(in child hair) at birth and at the age of 4 years.
Measurement of different endocrine disrupters
with oestrogenic activity in placentas.
Diet determinants:
 
•
 
Questionnaires: maternal diet assessment by a food
frequency questionnaire at two point interviews
(10–13 and 28–32 weeks of gestation). Infant and
child diet assessment by a breast-feeding question-
naire at the age of 1 year and a food frequency
questionnaire at the age of 4 years.
 
•
 
Biological samples: measurement of fatty acids,
vitamins C and E, and folate in maternal serum,
fatty acids in cord blood, vitamins E and C in breast
milk, and measurement of fatty acids and vitamins
at the age of 4 years.
Other determinants:
 
•
 
Oxidative stress (as underlying mechanism): mea-
surement of lipid hydroperoxides in maternal
serum (12 weeks’ gestation) and F2 isoprostanes in
urine at 12 and 32 weeks’ gestation, and child urine
at the age of 1 year.
 
•
 
Questionnaires: sociodemographic data, relevant
data about biological father, medical and obstetric
history, family history of allergies, use of drugs and
vaccinations during pregnancy, complications of the
current pregnancy at 12 and 32 weeks of gestation.
 
•
 
Genetic determinants: total blood will be stored to
measure genetic determinants for the different out-
comes in the future.
 
•
 
Parental psychopathology: mental health of both
parents and maternal and paternal attachment to
the infant measured using a questionnaire at the
age of 1 year.
 
Assessment of outcomes (Table 3)
 
Reproductive outcomes:
 
•
 
Intrauterine growth measured by fetal biometry
assessed longitudinally by ultrasound scans at 12,
 
Table 3.
 
Main outcomes to be assessed in the new INMA cohorts (
 
n
 
 = 3300)
Prenatal period Postnatal period 
12 weeks 20 weeks 32 weeks Birth 1 year 4 years
Intrauterine growth Ultrasound Ultrasound Ultrasound
Sexual development Physical 
examination
Physical examination Physical examination
Postnatal growth Physical 
examination
Physical examination Physical examination
Neurodevelopment Dubowitz test Bayley scales McCarthy scales
Hyperactivity, social
competence
Thyroid hormones Maternal serum TSH screening Child serum
Asthma/atopy Maternal serum Questionnaire
Physical examination
Child serum
Questionnaire
TSH, thyroid stimulating hormone.
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20 and 32 weeks’ gestation in all women. The
measurements will include femur length, head
circumference, biparietal diameter and abdominal
circumference.
 
•
 
Anthropometric measures at birth (length, weight,
head circumference and abdominal circumference)
obtained by clinical examination.
 
•
 
Preterm delivery and pre-eclampsia: information
based on clinical records.
Postnatal growth and sexual development:
 
•
 
Child growth: height and weight examination at
the ages of 1 and 4 years. Clinical records of height
and weight every 6 months.
 
• Sexual development: clinical examination per-
formed by INMA researchers with a standardised
protocol at birth, at the age of 1 year and at the age
of 4 years.
Neurodevelopment:
• Neurodevelopment: Dubowitz test at birth; mental
and psychomotor measurement at the ages of 1 and
4 years with the Bayley Scales of Infant Devel-
opment and the McCarthy Scales respectively.
Measurement of child hyperactivity (based on the
DSM-IV) and social competence (California Pre-
school Social Competence Scales) through a ques-
tionnaire administered to the teachers at the age of
4 years.
• Thyroid status: measurement of thyroid stimulat-
ing hormone (TSH) at birth, and of free-T4, TSH
and total-T3 at the age of 4 years.
Asthma and atopy:
• Measurement of speciﬁc IgE in maternal serum
during pregnancy to assess maternal atopy.
• Assessment of asthma symptoms through
questionnaire.
Atopy: physical dermal examination at the age of
1 year and measurement of total IgE at the age of
4 years.
Data quality, control and management
The INMA ﬁeld staff such as interviewers, laboratory
technicians and project paediatricians have been spe-
ciﬁcally trained for the project. All measurements have
been tested for inter- and intra-reproducibility.
An electronic database has been prepared to monitor
the cohort in order to facilitate the follow-up and to
minimise the loss to follow-up. Information regarding
maternal identiﬁcation, inclusion number, information
required for the follow-up (such as enrolment date,
date of last menstrual period or expected date of deliv-
ery), and the calendar for the visits and the sampling
procedures is collected by the INMA staff. Some infor-
mation is also gathered on refusals in order to compare
basic sociodemographic characteristics between both
groups.
Conﬁdentiality is guaranteed by keeping the moni-
toring data ﬁle separated from the questionnaire infor-
mation and the biological samples.
Communication
The INMA Study aims to guarantee helpful communi-
cation to the participants of the INMA by collective
meetings and periodic bulletins, to communicate the
results to the general population through the web page
and other sources, to guarantee that INMA data are
published in the scientiﬁc press, and to provide useful
information to health professionals, health ofﬁcers and
politicians.
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